Article Blogging Invest San Diego 
Both Sides of the Table
OCTOBER 19, 2009
On December 2nd, 2006 I wrote the blog post published later in this post when I was CEO of startup Koral about my experiences in pitching VCs. After my company was acquired by Salesforce.com I was asked to stop blogging and they took over my blog as an asset in the sale of the company. My blog was wiped out.
Xconomy
JULY 26, 2016
The financing includes both new investment funding and a conversion of debt to equity, according to a notation in the filing. Adding to the confusion, the most-recent MoneyTree Report on San Diego venture capital activity shows that Ostendo raised almost $10 million in VC funding during the second quarter.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Both Sides of the Table
JUNE 3, 2010
And the broader question of whether VC’s will continue to invest in the Twitter ecosystem. Discussion: Had a long chat about PicClick , a company founded by Ryan Sit in San Diego. Total raised: $1.74mm – Read more: TechCrunch , Wired article. Estimated 15mm downloads to date. They sponsor TWiVC. LibreDigital.
Xconomy
OCTOBER 19, 2017
At least that’s the assertion of New York Times columnist Farhad Manjoo in an article Wednesday. Instead, the Bay Area—while, yes, still home to thirsty young entrepreneurs—is increasingly the stomping grounds of a few major tech companies that have come to dominate how we live, work, and play.
Xconomy
SEPTEMBER 21, 2016
At Xconomy, we have seen growing investments in the sector—both in a rash of new agtech startups and by bigger players such Monsanto, Bayer Crop Sciences, and Syngenta. The annual AgTech Investment Report from AgFunderNews found that investment in agriculture and food-related technology startups alone hit $4.6
Xconomy
JUNE 30, 2016
Ley, who published in January an article in Nature Drug Discovery about integrin drugs, cautions there’s still much debate amongst scientists about how integrins work. “I Morphic was formed by Polaris Partners and Leukon Investments in 2015. Tipirneni estimates that Morphic is a few years away from testing drugs in clinical trials.
Xconomy
MAY 30, 2016
I don’t know if it was their first investment, but they invested $75,000 in a researcher named Ken Olsen, at MIT. X: I read an article from 1998 that you were quoted in—it sounded like Stanford’s Niels Reimers helped MIT reorganize its patenting and licensing office in 1986 to make it more like Stanford’s model.
Expert insights. Personalized for you.
274 
Let's personalize your content